Omega 3 PUFA Market: Type, EPA, ALA, Others; Source; Form; Application; By Geography - Forecast 2014-2020

  • ID: 3501557
  • Report
  • Region: Global
  • 135 pages
  • IndustryARC
1 of 3
Omega 3 Poly Unsaturated Fatty Acid (PUFA) is a type of essential fats which cannot be synthesized by human body which necessitates intake through food, as it is significant for enhancing metabolic activities such as cardiovascular and cognitive functions. Omega 3 has emerged as one of the potential nutritional ingredients for its usage in fortified food products, nutritive drinks, supplements and pharmaceuticals. Omega 3 ingredients have been gaining high traction in the food & beverages industry with the flourishing fortified products segment.

The market has been analyzed based on different types of Omega 3 ingredients including Eicosapentaenoic Acid (EPA), Docosahexaenoic Acid (DHA) and Alphalinolenic Acid (ALA). DHA and EPA account for major share due to their application in products that reduce the risk of cardio-vascular diseases. Analysis on various sources of omega 3 such as Anchovy/sardines, tuna, salmon, cod, menhaden, krill and others is also covered in the report. Increasing stress on supply side of marine extracted omega 3 coupled with consumers’ inclination towards plant based diet fuels the growth of nut, plant, seed and algal sourced ingredient segments.

Booming nutrition industry and considerable emphasis on infant brain development has been the major driver for the usage of these nutrients in infant formula and baby food. In addition, mounting concern for cardiovascular health and availability of supplements and food targeted towards this health issue fuels the demand for Omega-3 ingredients. Pharmaceutical drug manufacturers from all around the world are developing technologies to increase the concentration of these ingredients in their products. Furthermore, the report includes analysis on patents and competitive landscape.

Key players of the market include:
Royal DSM (The Netherlands)
Aker BioMarine ASA (Norway)
BASF SE (Germany)
Croda International PLC (U.K.)
FMC Corporation (U.S.)

The market estimates are derived by considering several market dynamics, trends related to end-use industries and growth potential of omega 3 ingredients. Major factors including raw material availability, price fluctuations, trade of the raw materials, regulations as well as products are taken into account to estimate the current market and for forecasting. To substantiate the analysis, the opinions of executives of various omega 3 manufacturers, distributors, suppliers, regulatory bodies, food and supplement product providers have been considered to enhance the accuracy and validate the estimates.
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. OMEGA-3 PUFA ingredients - MARKET OVERVIEW
1.1. Introduction
1.2. Classification
1.2.1. Omega-3 PUFA Ingredients Market Classification: By Type
1.2.1.1. EICOSAPENTAENOIC ACID (EPA)
1.2.1.2. DOCOSAHEXAENOIC ACID (DHA)
1.2.1.3. ALPHA LINOLENIC ACID (ALA)
1.2.2. Omega-3 PUFA Ingredients Market Classification: By SOURCE
1.2.2.1. PLANT BASED SOURCES
1.2.2.2. MARINE ANIMALS
1.2.2.3. MICROALGAE
1.2.3. Omega-3 PUFA Market Classification: By END USE APPLICATION
1.2.3.1. PHARMACEUTICAL AND CLINICAL NUTRITION
1.2.3.2. INFANT FOODS
1.2.3.3. FORTIFIED FOODS AND BEVERAGES
1.2.3.4. NUTRITIONAL SUPPLEMENTS
1.2.3.5. PET FOODS
1.2.4. Omega-3 PUFA Ingredients Market Classification: By CHemical Composition
1.2.4.1. TRIGLYCERIDE (TG)
1.2.4.2. ETHYL ESTER (EE)
1.2.4.3. PHOSPHOLIPID (PL)
2. Omega 3 PUFA ingredients Market- Executive Summary
3. omega-3PUFA ingredients MARKET LANDSCAPE
3.1. Financial Analysis of key players
3.2. Product Benchmarking
3.3. patent analysis
4. Omega 3 pufa ingredients Market Forces
4.1. Market Drivers
4.1.1. Rapidly ageing population to drive the growth of omega-3 ingredients market
4.1.2. Increasing cardiovascular problems to propel the omega-3 products consumption
4.1.3. Omega-3 concentrates to witness high traction in pharmaceutical industry
4.1.4. Emerging economies to drive the consumption of omega-3 products
4.1.5. New Product developments to sustain the market growth
4.1.6. Rise in vegan population in developed countries to fuel the demand for algal and plant based omega 3 products
4.2. Constraints
4.2.1. Lack of standardisation of recommended daily intake (RDI) levels hampers the market growth
4.2.2. Sustainability issues poses a threat to the manufacturers on the supply side
4.3. challenges
4.3.1. publicity of false adverse health effects due to higher intake of omega 3
4.4. Market Attractiveness
4.4.1. Power of Suppliers
4.4.2. Power of buyers
4.4.3. Threat of substitutes
4.4.4. Threat of new entrants
4.4.5. Degree of competition
5. Omega-3 pufa ingredients Market – Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. opportunity Analysis
5.3.1. omega 3 based nutricosmetics: an untapped niche segment
6. omega-3 pufa ingredients market- by type
6.1. Introduction
6.1.1. Omega-3 Fatty Acids, encapsulated miracle of health benefits
6.1.2. EICOSAPENTAENOIC ACID (EPA)
6.1.3. DOCOSAHEXAENOIC ACID (DHA)
6.1.4. ALPHA LINOLENIC ACID (ALA)
6.2. Pharmaceutical & Clinical Nutrition
6.3. Infant Food
6.4. Fortified Foods and Beverages
6.5. Nutritional supplements
6.6. others
7. Omega-3 PUFA ingredients Market- By Source
7.1. Plant Based
7.2. Marine animals
7.2.1. Anchovy/ Sardines
7.2.2. Concentrates
7.2.3. Tuna
7.2.4. Salmon
7.2.5. Cod
7.2.6. Menhaden
7.2.7. Krill
7.2.8. Others
7.3. Micro algae
7.3.1. Demand for algae-based omega-3 PUFA ingredients to drive the market growth
8. omega-3 pufa ingredients market by Geography
8.1. Introduction
8.2. North America
8.3. Europe
8.4. Asia-Pacific
8.5. RoW
9. omega-3 PUFA ingredients market entropy
9.1. Product Launches: The most preferred growth strategy
9.1.1. New product launches
9.1.2. M&A’s, Agreements, parnerships, Expansions
10. Omega-3 PUFA ingredients Market- Company Profiles
10.1. GOLDEN OMEGA S.A.
10.1.1. BUSINESS OVERVIEW
10.1.2. FINANCIALS
10.1.3. PRODUCTS
10.1.4. DEVELOPMENTS
10.2. ORKLA ASA
10.2.1. BUSINESS OVERVIEW
10.2.2. FINANCIALS
10.2.3. Products
10.2.4. DEVELOPMENTS
10.3. Croda International PLC
10.3.1. Business Overview
10.3.2. financials
10.3.3. products
10.3.4. developments
10.4. Marine ingredients llc.
10.4.1. Overview
10.4.2. Financials
10.4.3. products
10.4.4. developments
10.5. tasa omega
10.5.1. BUSINESS OVERVIEW
10.5.2. financials
10.5.3. products
10.5.4. developments
10.6. KD Pharma Bexbach GmbH
10.6.1. Business Overview
10.6.2. FINANCIALS
10.6.3. products
10.6.4. developments
10.7. ROYAL DSM N.V.
10.7.1. Business Overview
10.7.2. Financials
10.7.3. Products
10.7.4. Developments
10.8. aker bio marine asa
10.8.1. overview
10.8.2. FINANCIALS
10.8.3. products
10.8.4. developments
10.9. FMC Corporation
10.9.1. Business Overview
10.9.2. financials
10.9.3. PRODUCTS
10.9.4. Developments
10.10. BASF SE
10.10.1. Business Overview
10.10.2. Financials
10.10.3. Products
10.10.4. Strategy
10.10.5. Developments
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
11. Appendix
11.1. list of abbreviations
11.2. Sources
11.3. Research Methodology
11.4. Expert Insights
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll